UBS Group’s Nomura Holdings NMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.15M | Sell |
146,340
-128,790
| -47% | -$1.11M | ﹤0.01% | 5444 |
|
|
2025
Q4 | $2.31M | Buy |
275,130
+106,291
| +63% | +$794K | ﹤0.01% | 4841 |
|
|
2025
Q3 | $1.23M | Sell |
168,839
-143,877
| -46% | -$1.01M | ﹤0.01% | 5388 |
|
|
2025
Q2 | $2.06M | Buy |
312,716
+144,665
| +86% | +$846K | ﹤0.01% | 4787 |
|
|
2025
Q1 | $1.03M | Sell |
168,051
-447,846
| -73% | -$2.85M | ﹤0.01% | 5269 |
|
|
2024
Q4 | $3.57M | Buy |
615,897
+490,492
| +391% | +$2.78M | ﹤0.01% | 4174 |
|
|
2024
Q3 | $655K | Buy |
125,405
+417
| +0.3% | +$2.37K | ﹤0.01% | 5016 |
|
|
2024
Q2 | $722K | Sell |
124,988
-11,100
| -8% | -$65.8K | ﹤0.01% | 4709 |
|
|
2024
Q1 | $874K | Sell |
136,088
-4,198
| -3% | -$23.3K | ﹤0.01% | 4706 |
|
|
2023
Q4 | $633K | Buy |
140,286
+6,479
| +5% | +$26.7K | ﹤0.01% | 4900 |
|
|
2023
Q3 | $538K | Sell |
133,807
-4,497
| -3% | -$17.9K | ﹤0.01% | 4595 |
|
|
2023
Q2 | $530K | Buy |
138,304
+11,495
| +9% | +$42.6K | ﹤0.01% | 4778 |
|
|
2023
Q1 | $482K | Sell |
126,809
-157,354
| -55% | -$621K | ﹤0.01% | 4721 |
|
|
2022
Q4 | $1.07M | Buy |
284,163
+16,138
| +6% | +$55.8K | ﹤0.01% | 4012 |
|
|
2022
Q3 | $884K | Buy |
268,025
+2,946
| +1% | +$10.7K | ﹤0.01% | 3844 |
|
|
2022
Q2 | $949K | Sell |
265,079
-8,113
| -3% | -$31K | ﹤0.01% | 3784 |
|
|
2022
Q1 | $1.15M | Buy |
273,192
+54,176
| +25% | +$245K | ﹤0.01% | 3956 |
|
|
2021
Q4 | $948K | Sell |
219,016
-40,543
| -16% | -$184K | ﹤0.01% | 4439 |
|
|
2021
Q3 | $1.28M | Buy |
259,559
+11,077
| +4% | +$55.3K | ﹤0.01% | 3971 |
|
|
2021
Q2 | $1.26M | Buy |
248,482
+13,459
| +6% | +$72.4K | ﹤0.01% | 3975 |
|
|
2021
Q1 | $1.26M | Buy |
235,023
+6,163
| +3% | +$36.4K | ﹤0.01% | 4018 |
|
|
2020
Q4 | $1.22M | Buy |
228,860
+3,394
| +2% | +$16.8K | ﹤0.01% | 3856 |
|
|
2020
Q3 | $1.03M | Sell |
225,466
-4,585
| -2% | -$22.3K | ﹤0.01% | 3611 |
|
|
2020
Q2 | $1.02M | Buy |
230,051
+23,738
| +12% | +$98.8K | ﹤0.01% | 3491 |
|
|
2020
Q1 | $881K | Buy |
206,313
+30,703
| +17% | +$146K | ﹤0.01% | 3462 |
|
|
2019
Q4 | $906K | Buy |
175,610
+17,281
| +11% | +$83.4K | ﹤0.01% | 4314 |
|
|
2019
Q3 | $673K | Sell |
158,329
-1,409
| -0.9% | -$5.35K | ﹤0.01% | 4302 |
|
|
2019
Q2 | $567K | Sell |
159,738
-107,703
| -40% | -$376K | ﹤0.01% | 4199 |
|
|
2019
Q1 | $960K | Buy |
267,441
+5,349
| +2% | +$20.9K | ﹤0.01% | 3618 |
|
|
2018
Q4 | $975K | Sell |
262,092
-783
| -0.3% | -$3.51K | ﹤0.01% | 3712 |
|
|
2018
Q3 | $1.26M | Sell |
262,875
-9,711
| -4% | -$46K | ﹤0.01% | 3638 |
|
|
2018
Q2 | $1.31M | Sell |
272,586
-131,163
| -32% | -$714K | ﹤0.01% | 3546 |
|
|
2018
Q1 | $2.36M | Sell |
403,749
-317
| -0.1% | -$1.97K | ﹤0.01% | 2997 |
|
|
2017
Q4 | $2.35M | Buy |
404,066
+5,261
| +1% | +$30.5K | ﹤0.01% | 3052 |
|
|
2017
Q3 | $2.22M | Buy |
398,805
+11,137
| +3% | +$63.8K | ﹤0.01% | 3037 |
|
|
2017
Q2 | $2.34M | Buy |
387,668
+153,958
| +66% | +$942K | ﹤0.01% | 2863 |
|
|
2017
Q1 | $1.47M | Sell |
233,710
-58,378
| -20% | -$374K | ﹤0.01% | 3213 |
|
|
2016
Q4 | $1.72M | Sell |
292,088
-47,131
| -14% | -$251K | ﹤0.01% | 3052 |
|
|
2016
Q3 | $1.51M | Buy |
339,219
+6,528
| +2% | +$28.2K | ﹤0.01% | 3092 |
|
|
2016
Q2 | $1.17M | Sell |
332,691
-13,178
| -4% | -$54.9K | ﹤0.01% | 3239 |
|
|
2016
Q1 | $1.54M | Sell |
345,869
-198,411
| -36% | -$939K | ﹤0.01% | 2902 |
|
|
2015
Q4 | $3.02M | Sell |
544,280
-447
| -0.1% | -$2.73K | ﹤0.01% | 2420 |
|
|
2015
Q3 | $3.17M | Buy |
544,727
+237,809
| +77% | +$1.57M | ﹤0.01% | 2317 |
|
|
2015
Q2 | $2.08M | Buy |
306,918
+134,899
| +78% | +$880K | ﹤0.01% | 2942 |
|
|
2015
Q1 | $1.01M | Buy |
172,019
+17,440
| +11% | +$99.7K | ﹤0.01% | 3569 |
|
|
2014
Q4 | $876K | Buy |
+154,579
| New | +$915K | ﹤0.01% | 3680 |
|
Other funds holding NMR
DSC
QCM
UBS Group's NMR Position: Q1 2026 in Review
UBS Group reduced its Nomura Holdings (NMR) stake by 47% in Q1 2026, selling an estimated $1.11M and leaving 146,340 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5444.
UBS Group first reported a position in NMR in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.57M in Q4 2024. 271 funds tracked by Wall St. Rank hold NMR as of Q1 2026.
- UBS Group held 146,340 shares of Nomura Holdings worth $1.15M as of Q1 2026.
- UBS Group sold 128,790 Nomura Holdings shares in Q1 2026, an estimated $1.11M.
- Nomura Holdings made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5444 holding.
- UBS Group first reported a position in Nomura Holdings in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Nomura Holdings position peaked at $3.57M in Q4 2024.
- 271 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.